These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17142202

  • 1. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy.
    Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G.
    Adv Ther; 2006; 23(5):680-95. PubMed ID: 17142202
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM, Glynn RJ, Danielson E, Ridker PM, Val-MARC Investigators.
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [Abstract] [Full Text] [Related]

  • 7. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC, Ayala DE, Mojón A, Fontao MJ, Fernández JR.
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
    Mallion JM, Carretta R, Trenkwalder P, Martinez JF, Tykarski A, Teitelbaum I, Oddou P, Fagan T, Co-Diovan Study Group.
    Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of hydrochlorothiazide in combination with telmisartan and olmesartan in adults with moderate hypertension not controlled with monotherapy: a prospective, randomized, open-label, blinded end point (PROBE), parallel-arm study.
    Fogari R, Zoppi A, Mugellini A, Preti P, Destro M, Rinaldi A, Derosa G.
    Curr Ther Res Clin Exp; 2008 Feb; 69(1):1-15. PubMed ID: 24692778
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.
    Fuenfstueck R, Hempel RD, Ansari A, Weidinger G, Klebs S.
    Adv Ther; 2005 Feb; 22(3):263-77. PubMed ID: 16236687
    [Abstract] [Full Text] [Related]

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 15. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
    Wellington K, Faulds DM.
    Drugs; 2002 Jan; 62(13):1983-2005. PubMed ID: 12215069
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
    Tuomilehto J, Tykarski A, Baumgart P, Reimund B, Le Breton S, Ferber P.
    Blood Press Suppl; 2008 Jun; 1():15-23. PubMed ID: 18705531
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of irbesartan/ hydrochlorothiazide and valsartan/hydrochlorothiazide combination in lowering blood pressure: a retrospective observational study in Oman.
    Al Balushi KA, Habib JQ, Al-Zakwani I.
    Med Princ Pract; 2013 Feb; 22(3):265-9. PubMed ID: 23235349
    [Abstract] [Full Text] [Related]

  • 19. Effects of valsartan/hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients.
    Malacco E, Piazza S, Scandiani L, Zoppi A.
    Adv Ther; 2004 Feb; 21(3):149-61. PubMed ID: 15509131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.